Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1998-03-02
1999-12-14
Gitomer, Ralph
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514312, 514313, 514318, 514331, 546300, 546304, 546311, C07D21170, C07D21373, A01N 4340
Patent
active
060018569
ABSTRACT:
The present invention relates to the use of certain .beta.-adrenergic agonists to reduce a wasting condition in a mammal (e.g., human).
REFERENCES:
patent: 4358455 (1982-11-01), Atkinson et al.
patent: 5561142 (1996-10-01), Fisher et al.
patent: 5597843 (1997-01-01), Girten et al.
patent: 5714506 (1998-02-01), Fisher et al.
Krief, Stephanie, et al., J. Clin. Invest. vol. 91, Jan. 1993, pp. 344-349, "Tissue Distribution of .beta.3-adrenergic Receptor mRNA in Man".
Simiand, Jacques, et al., European Journal of Pharmacology vol. 219 (1992), pp. 193-201, "Antidepressant profile in rodents of SR 58611A, a new selective agonist for atypical .beta.-andrenoceptors".
Giudice, Antonina, et al, Life Sciences, vol. 44, (19), (1989), pp. 1411-1417, "Inhibition of Rat Colonic Motility and Cardiovascular Effects of New Gut-Specific Bata-Adrenergic Phenylethanolominotetralines".
Tesfamariam, Belay, et al., Br. J. Pharmacol. (1994), 112, pp. 55-58, ".beta..sub.1 -and .beta..sub.2 -adrenoceptor antagonist activities of ICI-215001,a putative .beta..sub.3 -adrenoceptor agonist".
Martin, Corinne A.E., et al., Br. J. Pharmacol. (1993), 110, pp. 1311-1316, "Effects of two .beta..sub.3 -adrenoceptor agonists, SR 58611A and BRL 37344, and of salbutamol on cholinergic and NANC neural contraction in guinea-pig main bronchi in vitro".
Taneja, D.T., et al., J. Pharm and Exp. Therapeutics, vol. 260, 1, (1992), pp. 192-200, "Evidence for a Noradrenergic Innervation to "Atypical" Beta Adrenoceptors (or Putative Beta-3 Adrenoceptors) in the Ileum of Guinea Pig .sup.1 ".
Kim, Yong S., et al., Life Sciences, vol. 50, pp. 397-407, "Minireview--.beta.-Adrenergic Agonists and Hypertrophy of Skeletal Muscles .sup.1 " (1992).
Benson Gregg C.
Gitomer Ralph
Moran Marjorie A.
Olson A. Dean
Pfizer Inc.
LandOfFree
.beta.-adrenergic agonists to reduce a wasting condition does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with .beta.-adrenergic agonists to reduce a wasting condition, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and .beta.-adrenergic agonists to reduce a wasting condition will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-863805